Sonendo Inc

SONX 4 | $0.0947 3.6% 430K

(0.0% 1d) (-14.3% 1m) (-94.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (102.87% volume)
Earnings Calendar:
Market Cap: $ 6,671,603
https://sonendo.com
Sec Filling | Patents | 2021 employees

Sonendo is a company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo has developed the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The GentleWave System, the first and only FDA-cleared system for root canal therapy, or RCT, that employs a sterilized, single-use Procedure Instrument, to transform RCT by addressing the limitations of conventional methods. The system utilizes its proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.

energy optical

add to watch list Paper trade email alert is off

Press-releases

Sonendo, Inc. to Report Third Quarter 2023 Financial Results on November 8, 2023
Published: 2023-10-25 (Crawled : 13:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -60.87% | O: 8.7% H: 4.0% C: -6.0%
report financial results

Sonendo, Inc. Announces Preliminary Revenue Results for the Third Quarter 2023
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -76.01% | O: 9.17% H: 9.89% C: -0.71%
results

Sonendo Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -71.88% | O: 25.0% H: 0.0% C: -22.5%
gentlewave partnership treatment sonendo root

Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08 - September 26, 2023
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -88.61% | O: 0.0% H: 0.0% C: -1.32%
grants

Sonendo to Participate at the LD Micro Main Event XVI Conference
Published: 2023-09-20 (Crawled : 16:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -89.23% | O: -0.69% H: 1.2% C: -1.2%
conference sonendo

Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase
Published: 2023-09-18 (Crawled : 14:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -89.63% | O: 2.55% H: 3.37% C: -4.49%
company group sonendo growth

Sonendo's Enhanced CleanFlow™ Procedure Instrument Now Indicated for Use on Anterior Teeth
Published: 2023-08-01 (Crawled : 14:20) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -93.02% | O: 0.78% H: 9.23% C: 7.69%

Sonendo, Inc. to Report Second Quarter 2023 Financial Results on August 9, 2023
Published: 2023-07-19 (Crawled : 12:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -92.37% | O: 5.93% H: 10.4% C: 6.4%
report financial results

Sonendo to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
Published: 2023-05-31 (Crawled : 13:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -92.8% | O: 2.7% H: 0.49% C: -1.07%
conference global sonendo

Sonendo, Inc. to Report First Quarter 2023 Financial Results on May 9, 2023
Published: 2023-04-18 (Crawled : 12:00) - biospace.com/
SONX 4 | $0.0947 3.6% 430K

Manufacturing

| -94.8% | O: -1.73% H: 0.58% C: -7.06%
report financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001562180-24-003434	4	2024-04-16	2024-04-15	Sell	S	481	51506
0001562180-24-003026	4	2024-03-27	2024-03-26	Sell	S	2625	243061
0001562180-24-003025	4	2024-03-27	2024-03-26	Sell	S	11493	1934139